Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Richard

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Leukemia|December 15, 2023
DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AMLJean-François Spinella, Jalila Chagraoui, Céline Moison, et al.
Blood Advances|August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapseBachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
International Journal of Clinical Pharmacy|March 28, 2023
Self-perceived role and knowledge of community pharmacists in organ donationFrancis Flynn, Marc-Alexandru Dobrescu, Guillaume Richard, et al.
Biomarker Research|October 24, 2025
High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohortGuillaume Richard-Carpentier, François Béliveau, Sandrine Lacoste, et al.
European Journal of Haematology|August 8, 2024
Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AMLElliot Smith, Eshetu G Atenafu, Aniket Bankar, et al.
Communications Biology|July 9, 2024
A foundational large language model for edible plant genomesJavier Mendoza-Revilla, Evan Trop, Liam Gonzalez, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?Akhil Rajendra, Elliot Smith, Eshetu G Atenafu, et al.
Nature Methods|November 28, 2024
Nucleotide Transformer: building and evaluating robust foundation models for human genomicsHugo Dalla-Torre, Liam Gonzalez, Javier Mendoza-Revilla, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2020
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaGuillaume Richard-Carpentier, Elias Jabbour, Nicholas J Short, et al.
The Journal of Molecular Diagnostics : JMD|August 8, 2021
Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing AssayChristina K Ferrone, Henry Wong, Laura Semenuk, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Leukemia|December 15, 2023
DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AMLJean-François Spinella, Jalila Chagraoui, Céline Moison, et al.
Blood Advances|August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapseBachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
International Journal of Clinical Pharmacy|March 28, 2023
Self-perceived role and knowledge of community pharmacists in organ donationFrancis Flynn, Marc-Alexandru Dobrescu, Guillaume Richard, et al.
Biomarker Research|October 24, 2025
High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohortGuillaume Richard-Carpentier, François Béliveau, Sandrine Lacoste, et al.
European Journal of Haematology|August 8, 2024
Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AMLElliot Smith, Eshetu G Atenafu, Aniket Bankar, et al.
Communications Biology|July 9, 2024
A foundational large language model for edible plant genomesJavier Mendoza-Revilla, Evan Trop, Liam Gonzalez, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?Akhil Rajendra, Elliot Smith, Eshetu G Atenafu, et al.
Nature Methods|November 28, 2024
Nucleotide Transformer: building and evaluating robust foundation models for human genomicsHugo Dalla-Torre, Liam Gonzalez, Javier Mendoza-Revilla, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2020
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaGuillaume Richard-Carpentier, Elias Jabbour, Nicholas J Short, et al.
The Journal of Molecular Diagnostics : JMD|August 8, 2021
Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing AssayChristina K Ferrone, Henry Wong, Laura Semenuk, et al.
Pageof 4